The abstract is read at the publisher; the summary is JClub's.
In a cohort of people with treatment-resistant schizophrenia, serum iron, selenium, and rubidium show robust, discriminating alterations versus controls, independent of age and clozapine levels.
- Why it matters: The work targets a gap in how dysregulated brain metals and oxidative stress pathways relate to schizophrenia, especially in treatment-resistant cases.
- What they did: Using a metallomics approach, the study measured serum pro-oxidant iron, anti-oxidant selenium, and rubidium, alongside cytokines, hepcidin, and anti-oxidant selenoproteins SEPP1 and GPX3.
- The result: TRS cases had elevated serum pro-inflammatory cytokines and hepcidin, with lower SEPP1 and GPX3, implying peripheral metal–inflammation links that may relate to hepcidin-driven iron changes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.